hit
counter

Press Releases

Citius' Mino-Lok™ Addresses Resistant Pathogens

Jan 11, 2017

Citius Pharmaceuticals to Present at 9th Annual Biotech Showcase

Dec 21, 2016

Drug Master File Submitted to FDA for Citius' Ethanol

Dec 19, 2016

Citius Moves Forward with Mino-Lok™ Phase 3 Trial

Dec 8, 2016

Citius Pharmaceuticals to Present at the Dawson James 2016 Small Cap Growth Stock Conference

Oct 20, 2016

Citius Pharmaceuticals to Present at the 2016 Aegis Growth Conference

Sep 19, 2016

Citius Initiates Mino-Lok™ Phase 3 Trial

Sep 13, 2016

Citius Pharmaceuticals, Inc., Initiates Manufacturing of Mino-Lok™

Sep 8, 2016

Citius Pharmaceuticals to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

Sep 7, 2016

Citius Announces Completion of In-Depth Interviews on Patient-Reported Outcomes: Signs and Symptoms of Hemorrhoids and Treatments

Aug 23, 2016

© 2019 Citius Pharmaceuticals | Disclaimer & Terms of Use